Augmentation of Extracellular ATP Synergizes With Chemotherapy in Triple Negative Breast Cancer

Augmentation of Extracellular ATP Synergizes With Chemotherapy in Triple Negative Breast Cancer

IntroductionBreast cancer affects two million patients worldwide every year and is the most common cause of cancer-related death among women. The triple-negative breast cancer (TNBC) sub-type is associated with an especially poor prognosis because currently available therapies fail to induce long-la...

Full description

Bibliographic Details
Main Authors: Jasmine M. Manouchehri, Jharna Datta, Natalie Willingham, Robert Wesolowski, Daniel Stover, Ramesh K. Ganju, William E. Carson, Bhuvaneswari Ramaswamy, Mathew A. Cherian
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Oncology
Subjects:
ATP
breast cancer
paclitaxel
P2RX4
P2RX7
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.855032/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.855032/full

Similar Items